Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medical Physics|July 21, 2004
Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermiaUwe Gneveckow, Andreas Jordan, Regina Scholz, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastomaMichail Plotkin, Uwe Gneveckow, Klaus Meier-Hauff, et al.
The Prostate|August 23, 2005
Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancerManfred Johannsen, Burghard Thiesen, Uwe Gneveckow, et al.
European Urology|November 28, 2006
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distributionManfred Johannsen, Uwe Gneveckow, Burghard Thiesen, et al.
Actas Urologicas Espanolas|September 28, 2007
[Thermal therapy of prostate cancer using magnetic nanoparticles]Manfred Johannsen, Uwe Gneveckow, Kasra Taymoorian, et al.
The Prostate|February 24, 2005
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat modelManfred Johannsen, Burghard Thiesen, Andreas Jordan, et al.
Journal of Neuro-Oncology|June 15, 2006
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiformeKlaus Maier-Hauff, Ronny Rothe, Regina Scholz, et al.
Plos One|May 5, 2009
A systematic proteomic study of irradiated DNA repair deficient Nbn-miceAnna Melchers, Lars Stöckl, Janina Radszewski, et al.
Journal of Neuro-Oncology|November 30, 2005
The effect of thermotherapy using magnetic nanoparticles on rat malignant gliomaAndreas Jordan, Regina Scholz, Klaus Maier-Hauff, et al.
Blood Cells, Molecules & Diseases|February 25, 2005
Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptorMatthias Holdhoff, Karl-Anton Kreuzer, Christine Appelt, et al.
Pageof 4